BioCryst appoints Babar Ghias as CFO

4 hours ago 1
  • BioCryst Pharmaceuticals (NASDAQ:BCRX) on Monday announced the appointment of Babar Ghias as chief financial officer and head of corporate development.
  • Ghias joins BioCryst from AvenCell Therapeutics, where he served as CFO since 2022.
  • Previously, Ghias was executive vice president of investments

Recommended For You

More Trending News

Read Entire Article